Home › Sjogren's Syndrome › Arizona
Sjogren's Syndrome clinical trials in Arizona
4 studies for Sjogren's Syndrome are looking for participants at sites in Arizona.
Cities in Arizona
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Sun Valley Arthritis Center Ltd, Peoria
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Arizona Arthritis & Rheumatology Associates P.C., Chandler
- Arizona Arthritis & Rheumatology Associates P.C., Flagstaff
- Arizona Arthritis & Rheumatology Associates, PLLC, Glendale
- and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Phoenix, Phoenix
- Artiva Investigational Site Tucson, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Arizona Arthritis & Rheumatology Associates - Avondale, Avondale
- Arizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln, Flagstaff
- Arizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St, Gilbert
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.